blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3565557

EP3565557 - METHODS AND COMPOSITIONS FOR CANCER THERAPIES THAT INCLUDE DELIVERY OF HALOGENATED THYMIDINES AND THYMIDINE PHOSPHORYLASE INHIBITORS IN COMBINATION WITH RADIATION [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  25.08.2022
Database last updated on 03.10.2024
FormerRequest for examination was made
Status updated on  11.10.2019
FormerThe international publication has been made
Status updated on  13.07.2018
Most recent event   Tooltip28.09.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
Shuttle Pharmaceuticals, Inc.
1 Research Court, Suite 450
Rockville, MD 20850-6252 / US
[2019/46]
Inventor(s)01 / GRINDROD, Scott
c/o Shuttle Pharmaceuticals LLC
1 Research Court
Suite 450
Rockville MD 20850-6252 / US
02 / TIMOFEEVA, Olga
c/o Shuttle Pharmaceuticals LLC
1 Research Court
Suite 450
Rockville MD 20850-6252 / US
03 / BROWN, Milton
c/o Shuttle Pharmaceuticals LLC
1 Research Court
Suite 450
Rockville MD 20850-6252 / US
04 / JUNG, Mira
c/o Shuttle Pharmaceuticals LLC
1 Research Court
Suite 450
Rockville MD 20850-6252 / US
05 / DRITSCHILO, Anatoly
c/o Shuttle Pharmaceuticals, LLC
1 Research Court
Suite 450
Rockville MD 20850-6252 / US
 [2019/46]
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2019/46]Parchmann, Stefanie
Maiwald Patentanwalts- und
Rechtsanwaltsgesellschaft mbH
Elisenhof
Elisenstraße 3
80335 München / DE
Application number, filing date18736185.209.01.2018
[2019/46]
WO2018US12914
Priority number, dateUS201762444155P09.01.2017         Original published format: US 201762444155 P
[2019/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018129514
Date:12.07.2018
Language:EN
[2018/28]
Type: A1 Application with search report 
No.:EP3565557
Date:13.11.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 12.07.2018 takes the place of the publication of the European patent application.
[2019/46]
Search report(s)International search report - published on:US12.07.2018
(Supplementary) European search report - dispatched on:EP30.10.2020
ClassificationIPC:A61K31/505, A61K31/513, A61K31/7072, A61P35/00
[2020/49]
CPC:
A61K31/7072 (EP,US); A61K31/513 (EP,US); A61K33/243 (EP,US);
A61P35/00 (EP); A61K2121/00 (US)
C-Set:
A61K31/513, A61K2300/00 (EP);
A61K31/7072, A61K2300/00 (EP)
Former IPC [2019/46]A61K31/505, A61K31/513, A61K31/7072
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/46]
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN FÜR KREBSTHERAPIEN MIT ABGABE VON HALOGENIERTEN THYMIDINE UND THYMIDIN-PHOSPHORYLASE-INHIBITOREN IN KOMBINATION MIT STRAHLUNG[2019/46]
English:METHODS AND COMPOSITIONS FOR CANCER THERAPIES THAT INCLUDE DELIVERY OF HALOGENATED THYMIDINES AND THYMIDINE PHOSPHORYLASE INHIBITORS IN COMBINATION WITH RADIATION[2019/46]
French:PROCÉDÉS ET COMPOSITIONS POUR THÉRAPIES ANTICANCÉREUSES COMPRENANT L'ADMINISTRATION DE THYMIDINES HALOGÉNÉES ET D'INHIBITEURS DE LA THYMIDINE PHOSPHORYLASE EN COMBINAISON AVEC UN RAYONNEMENT[2019/46]
Entry into regional phase25.07.2019National basic fee paid 
25.07.2019Search fee paid 
25.07.2019Designation fee(s) paid 
25.07.2019Examination fee paid 
Examination procedure25.07.2019Examination requested  [2019/46]
25.05.2021Amendment by applicant (claims and/or description)
24.08.2022Despatch of a communication from the examining division (Time limit: M04)
19.12.2022Reply to a communication from the examining division
27.09.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
27.01.2020Renewal fee patent year 03
27.01.2021Renewal fee patent year 04
27.01.2022Renewal fee patent year 05
27.01.2023Renewal fee patent year 06
29.01.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2009138507  (UNIV LEUVEN KATH [BE], et al);
International search[Y]US2008161292  (GIRANDA VINCENT L [US], et al);
 [Y]US2012010165  (FUKUSHIMA MASAKAZU [JP]);
 [Y]WO2016044690  (SHUTTLE PHARMACEUTICALS LLC [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.